Iran Diabetes Care Devices Market Size (2024 - 2029)

The Iran Diabetes Care Devices Market is projected to experience growth over the forecast period, driven by increasing diabetes prevalence and the need for effective management solutions. Despite challenges such as medication shortages, disrupted care routines, and inadequate infrastructure, the market is expected to expand. The impact of sanctions and the COVID-19 pandemic has further complicated diabetes care, highlighting the importance of self-management practices like regular monitoring and adherence to treatment. These factors collectively influence the market's expansion and development.

Home Market Analysis Healthcare Research Device Drug Combination Research Diagnostics and Therapeutics Research Diabetes Care Research Diabetes Care Devices Market in Iran Market Size

Market Size of Iran Diabetes Care Devices Industry

Iran Diabetes Care Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 752.91 Million
Market Size (2029) USD 938.26 Million
CAGR (2024 - 2029) 4.50 %

Major Players

Iran Diabetes Care Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Iran Diabetes Care Devices Market Analysis

The Iran Diabetes Care Devices Market size is estimated at USD 752.91 million in 2024, and is expected to reach USD 938.26 million by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).

The most significant challenges of diabetes care management in developing countries during the COVID-19 pandemic include inadequate preventive measures, interrupted traditional methods of relationship with the patient, medication shortages, disruption of routine diabetic care, and a lack of the necessary infrastructure for telehealth services. Diabetes prevalence is increasing in Iran, as in many other nations. In addition to the problems inherent in diabetes management in impoverished nations, Iran has encountered new hurdles in the last two years as sanctions have tightened. During the COVID-19 crisis in Iran, the weight of sanctions more than quadrupled.

The most important components of diabetes self-management that should be considered to control hyperglycemia better and prevent or at least delay complications in diabetic patients are regular blood glucose monitoring, following a healthy diet, regular physical activity, and compliance with medication and foot care. Shortages or the high prices of devices such as insulin pens escalated the anxiety of patients with diabetes and complicated the management of their disease during the COVID-19 crisis.

Iran Diabetes Care Devices Industry Segmentation

CGM devices consist of three essential components: a sensor, a transmitter, and a receiver or monitor. The sensor, a compact device, is gently inserted beneath the skin to continuously monitor blood sugar levels, providing real-time measurements multiple times per minute. Subsequently, the transmitter relays this valuable information to a receiver, which can either be integrated into an insulin pump or exist as a standalone device. Iran diabetes care devices market is segmented into devices (management devices (insulin pumps, insulin pens, syringes, cartridges, and jet injectors) and monitoring devices (self-monitoring blood and continuous glucose monitoring)). The report offers the market size in value terms in USD and volume terms in units for all the abovementioned segments.

Monitoring Devices
Self-monitoring Blood Glucose Devices
Glucometer Devices
Test Strips
Lancets
Continuous Blood Glucose Monitoring
Sensors
Durables
Management Devices
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Insulin Cartridges
Disposable Pens
Need A Different Region Or Segment?
Customize Now

Iran Diabetes Care Devices Market Size Summary

The Iran diabetes care devices market is poised for steady growth over the forecast period, driven by an increasing prevalence of diabetes and the adoption of advanced monitoring technologies. Despite challenges such as economic sanctions, high costs of diabetes management, and limited access to essential medications like insulin, the market is expanding due to the rising demand for insulin management devices and continuous glucose monitoring systems. The COVID-19 pandemic exacerbated existing issues, including medication shortages and disrupted care routines, but also highlighted the importance of self-management practices such as regular blood glucose monitoring and adherence to dietary and physical activity guidelines. The economic impact of diabetes in Iran is significant, with high direct healthcare costs contributing to the financial burden on families and the healthcare system.

The market landscape is characterized by technological advancements and strategic collaborations among key players. Companies like Medtronic, Roche, NovoNordisk, Abbott, and Dexcom are at the forefront, with innovations such as the MiniMed 780G system and partnerships with health-tech firms to enhance diabetes care. These developments are paving the way for automated insulin delivery systems and improved monitoring devices, addressing the needs of patients in challenging economic conditions. Despite the availability of drugs and insulin coverage, the control of diabetes-related health issues remains inadequate, underscoring the ongoing need for effective diabetes care solutions in Iran. As the market continues to evolve, it is expected to gradually expand, supported by advancements in technology and increased awareness of diabetes management.

Explore More

Iran Diabetes Care Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Monitoring Devices

      1. 2.1.1 Self-monitoring Blood Glucose Devices

        1. 2.1.1.1 Glucometer Devices

        2. 2.1.1.2 Test Strips

        3. 2.1.1.3 Lancets

      2. 2.1.2 Continuous Blood Glucose Monitoring

        1. 2.1.2.1 Sensors

        2. 2.1.2.2 Durables

    2. 2.2 Management Devices

      1. 2.2.1 Insulin Pump

        1. 2.2.1.1 Insulin Pump Device

        2. 2.2.1.2 Insulin Pump Reservoir

        3. 2.2.1.3 Infusion Set

      2. 2.2.2 Insulin Syringes

      3. 2.2.3 Insulin Cartridges

      4. 2.2.4 Disposable Pens

Iran Diabetes Care Devices Market Size FAQs

The Iran Diabetes Care Devices Market size is expected to reach USD 752.91 million in 2024 and grow at a CAGR of 4.5% to reach USD 938.26 million by 2029.

In 2024, the Iran Diabetes Care Devices Market size is expected to reach USD 752.91 million.

Iran Diabetes Care Devices Market Report Snapshots

Iran Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)